Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$20.34 USD
+0.83 (4.25%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $20.38 +0.04 (0.20%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
CSTL 20.34 +0.83(4.25%)
Will CSTL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CSTL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CSTL
Castle Biosciences, Inc. (CSTL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
CSTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Insights Into Castle Biosciences, Inc. (CSTL) Q4: Wall Street Projections for Key Metrics
Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?
How Much Upside is Left in Castle Biosciences, Inc. (CSTL)? Wall Street Analysts Think 67.01%
Other News for CSTL
The Melanoma Research Foundation to host the DC Miles for Melanoma 5K
The Melanoma Research Foundation to host the New England Miles for Melanoma 5K
CSTL Makes Notable Cross Below Critical Moving Average
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations